Comparative genomics reveals distinct immune-oncologic pathways in African American men with prostate cancer January 7, 2021 Racial disparities in prostate cancer are prevalent in the United States as African American men consistently experience a higher burden of prostate cancer incidence compared to European American men. While socioeconomic status, access to optimal care, and lifestyle factors can explain a part of these disparities, distinct molecular mechanisms and underlying biologic differences in African American men remain a major contributor to prostate cancer disparities. Advancements in research on the immune landscape of prostate cancer in European American men have lacked validation among their African American counterparts.Read the full article here. Source: Uro Today About Prostate Cancer Genomic Testing Prostate Cancer News Radiation Oncology More for you
Racial disparities in prostate cancer are prevalent in the United States as African American men consistently experience a higher burden of prostate cancer incidence compared to European American men. While socioeconomic status, access to optimal care, and lifestyle factors can explain a part of these disparities, distinct molecular mechanisms and underlying biologic differences in African American men remain a major contributor to prostate cancer disparities. Advancements in research on the immune landscape of prostate cancer in European American men have lacked validation among their African American counterparts.Read the full article here. Source: Uro Today
